- ►annals.org [PDF] GS Hoffman, MC Cid, KE Rendt-Zagar, PA … - Annals of Internal Medicine, 2007 - Am Coll Physicians Gary S. Hoffman, MD; Maria C. Cid, MD; Karen E. Rendt-Zagar, MD; Peter A.
Merkel, MD, MPH; Cornelia M. Weyand, MD; John H. Stone, MD, MPH; Carlo
Salvarani, MD; Weichun Xu, PhD; Sudha Visvanathan, PhD; and Mahboob U. ... Cited by 66 - Related articles - BL Direct - All 3 versions
- ►annals.org [PDF] C Salvarani, PL Macchioni, C Manzini, G … - Annals of internal medicine, 2007 - Am Coll Physicians Background: A reliable alternative to steroids for treating poly- myalgia
rheumatica has not yet been identified. Although infliximab has been used
occasionally in steroid-resistant cases, its efficacy has not been ... Cited by 44 - Related articles - BL Direct - All 7 versions
AD Mahr, JA Jover, RF Spiera, C Hernández- … - Arthritis & Rheumatism, 2007 - assets0.pubget.com Objective. To reevaluate the efficacy and safety of adjunctive low-dose
methotrexate (MTX) in giant cell arteritis (GCA). Methods. An individual patient
data meta- analysis of 3 randomized placebo-controlled trials in patients ... Cited by 43 - Related articles - View as HTML - BL Direct - All 5 versions
MS Lee, SD Smith, A Galor, GS Hoffman - Arthritis Rheum, 2006 - rheum.ca Objective. Vision loss and cerebrovascular acci- dents often complicate giant
cell arteritis (GCA). Anti- platelet and anticoagulant therapy reduce the risk
of stroke in other populations. We sought to determine whether antiplatelet ... Cited by 55 - Related articles - View as HTML - BL Direct - All 4 versions
MM Ahmed, E Mubashir, S Hayat, M Fowler, … - Clinical rheumatology, 2007 - Springer Abstract High-dose corticosteroids (CS) are the mainstay of treatment for
temporal (giant cell) arteritis (TA). A usually required long-term treatment
with CS, ranging from 1 to 5 years or more, frequently leads to serious ... Cited by 18 - Related articles - BL Direct - All 4 versions
F Cantini, L Niccoli, C Salvarani, A Padula, I … - Arthritis and rheumatism, 2001 - cat.inist.fr Treatment of longstanding active giant cell arteritis with infliximab: report
of four cases. Fabrizio CANTINI, Laura NICCOLI, Carlo ... Cited by 121 - Related articles - BL Direct - All 4 versions
- ►ufl.edu [PDF] CC Foundation, O Cleveland, M Clinic, M … - Arthritis Care & Research - interscience.wiley.com This was a multicenter, randomized, double-blind study. Over 4 years, 16 centers
from the International Network for the Study of Systemic Vasculitides enrolled
patients with unequivocal GCA. The initial treatment was 1 mg/kg/day ( 60 ... Cited by 130 - Related articles - BL Direct - All 10 versions
A Proven, SE Gabriel, C Orces, WM O'Fallon, … - Arthritis & Rheumatism, 2003 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 55 - Related articles - BL Direct - All 3 versions
RF Spiera, HJ Mitnick, M Kupersmith, M … - Clinical and Experimental Rheumatology, 2001 - clinexprheumatol.org Page 1. A prospective, double-blind, randomized, placebo controlled trial of
methotrexate in the treatment of giant cell arteritis (GCA) ... Cited by 75 - Related articles - View as HTML - BL Direct - All 4 versions
